Patient Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB, which includes delamanid and bedaquiline. Khayelitsha, Western Cape.
All Topics

Drug-resistant TB

 
Drug-resistant TB

MSF demands Johnson & Johnson reduce price of life-saving TB drug

Press Release 9 Oct 2019
 
Drug-resistant TB

Third new TB drug in over half a century must be affordable

Press Release 15 Aug 2019
 
Videos and Photos

Lives Over Profit: 20 years of fighting for access to lifesaving medicines

6 Aug 2019
Videos and Photos
 
Drug-resistant TB

No fair prices for medicine without access and transparency

Press Release 10 Apr 2019
 
Drug-resistant TB

TB activists challenge TB drug patent in India

Press Release 5 Feb 2019
 
Zimbabwe

MSF Zimbabwe Newsletter: Issue 1, 2019

Newsletter 29 Jan 2019